Matthew Brams - Feb 28, 2023 Form 4 Insider Report for Cingulate Inc. (CING)

Role
EVP and Chief Medical Officer
Signature
/s/ Jeff Bennett, Attorney-in-Fact
Stock symbol
CING
Transactions as of
Feb 28, 2023
Transactions value $
$0
Form type
4
Date filed
3/8/2023, 08:01 PM
Previous filing
Mar 1, 2022
Next filing
Mar 6, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CING Stock Option (right to Buy) Award $0 +15K $0.00 15K Feb 28, 2023 Common Stock 15K $1.79 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as follows: 25% on the one-year anniversary of the date of grant and the remaining shares in substantially equal monthly installments over the 36-month period following the initial vesting date.

Remarks:

Exhibit 24 - Power of Attorney